← Back to Treatments
🏅 FDA Orphan Designation

Sodium Phenylacetate And Sodium Benzoate

SODIUM PHENYLACETATE AND SODIUM BENZOATE

Manufacturer: Zydus Pharmaceuticals USA Inc.

Indicated for:📚 Hypermethioninemia encephalopathy due to adenosine kinase deficiency

Indications & Usage

1 INDICATIONS AND USAGE Sodium Phenylacetate and Sodium Benzoate Injection is a nitrogen binding agent indicated as adjunctive therapy for the treatment of acute hyperammonemia and associated encephalopathy in paediatric and adult patients with deficiencies in enzymes of the urea cycle. ( 1 ) Sodium Phenylacetate and Sodium Benzoate Injection is indicated as adjunctive therapy in pediatric and adult patients for the treatment of acute hyperammonemia and associated encephalopathy in patients with deficiencies in enzymes of the urea cycle. During acute hyperammonemic episodes, arginine supplementation, caloric supplementation, dietary protein restriction, hemodialysis, and other ammonia lowering therapies should be considered [ see Warnings and Precautions (5) ].

💙 Support Programs

View all →
Sodium Phenylacetate And Sodium Benzoate
Zydus Pharmaceuticals USA Inc.

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.